| Intravesical bacteriophages for treating urinary tract infections in patients undergoing transurethral resection of the prostate: a randomised, placebo-controlled, double-blind … L Leitner, A Ujmajuridze, N Chanishvili, M Goderdzishvili, I Chkonia, ... The Lancet Infectious Diseases 21 (3), 427-436, 2021 | 262 | 2021 |
| Quality and safety requirements for sustainable phage therapy products JP Pirnay, BG Blasdel, L Bretaudeau, A Buckling, N Chanishvili, JR Clark, ... Pharmaceutical research 32, 2173-2179, 2015 | 257 | 2015 |
| Bacteriophages for treating urinary tract infections in patients undergoing transurethral resection of the prostate: a randomized, placebo-controlled, double-blind clinical trial L Leitner, W Sybesma, N Chanishvili, M Goderdzishvili, A Chkhotua, ... BMC urology 17, 1-6, 2017 | 169 | 2017 |
| Adapted bacteriophages for treating urinary tract infections A Ujmajuridze, N Chanishvili, M Goderdzishvili, L Leitner, U Mehnert, ... Frontiers in microbiology 9, 1832, 2018 | 162 | 2018 |
| Characterization and Testing the Efficiency of Acinetobacter baumannii Phage vB-GEC_Ab-M-G7 as an Antibacterial Agent I Kusradze, N Karumidze, S Rigvava, T Dvalidze, M Katsitadze, ... Frontiers in microbiology 7, 1590, 2016 | 90 | 2016 |
| Immobilization of bacteriophage in wound-dressing nanostructure F Nogueira, N Karumidze, I Kusradze, M Goderdzishvili, P Teixeira, ... Nanomedicine: Nanotechnology, Biology and Medicine 13 (8), 2475-2484, 2017 | 76 | 2017 |
| Molecular detection of OXA carbapenemase genes in multidrug-resistant Acinetobacter baumannii isolates from Iraq and Georgia I Kusradze, SM Diene, M Goderdzishvili, JM Rolain International journal of antimicrobial agents 38 (2), 164-168, 2011 | 71 | 2011 |
| Bacteriophage Delivery by Nebulization and Efficacy Against Phenotypically Diverse Pseudomonas aeruginosa from Cystic Fibrosis Patients JS Sahota, CM Smith, P Radhakrishnan, C Winstanley, M Goderdzishvili, ... Journal of aerosol medicine and pulmonary drug delivery 28 (5), 353-360, 2015 | 60 | 2015 |
| What can we learn from a metagenomic analysis of a Georgian bacteriophage cocktail? H Zschach, KG Joensen, B Lindhard, O Lund, M Goderdzishvili, I Chkonia, ... Viruses 7 (12), 6570-6589, 2015 | 49 | 2015 |
| Characterization of lytic Pseudomonas aeruginosa bacteriophages via biological properties and genomic sequences N Karumidze, JA Thomas, N Kvatadze, M Goderdzishvili, KW Hakala, ... Applied Microbiology and Biotechnology 94, 1609-1617, 2012 | 46 | 2012 |
| Phage therapy experience at the eliava phage therapy center: Three cases of bacterial persistence E Zaldastanishvili, L Leshkasheli, M Dadiani, L Nadareishvili, ... Viruses 13 (10), 1901, 2021 | 34 | 2021 |
| Selection of Potential Therapeutic Bacteriophages that Lyse a CTX-M-15 Extended Spectrum β-Lactamase Producing Salmonella enterica Serovar Typhi Strain … E Kakabadze, K Makalatia, N Grdzelishvili, N Bakuradze, ... Viruses 10 (4), 172, 2018 | 26 | 2018 |
| Clinical phage therapy E Kutter, J Borysowski, R Miedzybrodzki, A Górski, B Weber-Dabrowska, ... Phage therapy: current research and applications, 257-288, 2014 | 21 | 2014 |
| Comparative analysis of the biological and physical properties of Enterococcus faecalis bacteriophage vB_EfaS_GEC-EfS_3 and Streptococcus mitis bacteriophage vB_SmM_GEC-SmitisM_2 S Rigvava, I Tchgkonia, D Jgenti, T Dvalidze, J Carpino, M Goderdzishvili Canadian journal of microbiology 59 (1), 18-21, 2013 | 21 | 2013 |
| Novel lytic bacteriophage vB_GEC_EfS_9 against Enterococcus faecium S Rigvava, I Kusradze, I Tchgkonia, N Karumidze, T Dvalidze, ... Virus Research 307, 198599, 2022 | 10 | 2022 |
| Phagebioderm–new prospects for treatment of wounds and trophic ulcers K Markoishvili, N Djavakhishvili, M Goderdzishvili, A Meipariani, ... Exp Clin Med 2, 83-84, 1999 | 8 | 1999 |
| Identification and antibiotic susceptibility patterns of streptococcus agalactiae. S Rigvava, S Kharebava, T Giorgobiani, T Dvalidze, M Goderdzishvili Georgian medical news, 149-153, 2019 | 7 | 2019 |
| 265 Phage therapy for the treatment for urinary tract infection: Results of in-vitro screenings and in-vivo application using commercially available bacteriophage cocktails A Uimajuridze, G Jvania, N Chanishvili, M Goderdzishvili, W Sybesma, ... European Urology Supplements 3 (15), e265, 2016 | 7 | 2016 |
| BIOLOGICAL CHARACTERIZATION OF BACTERIOPHAGES AGAINST STREPTOCOCCUS AGALACTIAE. S Rigvava, N Karumidze, I Kusradze, T Dvalidze, N Tatrishvili, ... Georgian Medical News, 182-186, 2021 | 4 | 2021 |
| Phage therapy for the treatment for urinary tract infection: Results of in-vitro screenings and in-vivo application using commercially available bacteriophage cocktails A Ujmajuridze, G Jvania, N Chanishvili, M Goderdzishvili, W Sybesma, ... Eur. Urol. Suppl 15, e265, 2016 | 4 | 2016 |
Nina ChanishviliHead of R & D Department, Eliava Institute of Bacteriophage, Microbiology & Virology在 pha.ge 的电子邮件经过验证
